Biomind Labs Inc Cash Flow-to-Debt Ratio
Biomind Labs Inc cash flow-to-debt ratio. Biomind Labs Inc (BMND) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of CA$-79.04K could theoretically repay 0% of its total liabilities (CA$1.90 Million) in one year. Check BMND cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biomind Labs Inc (2021–2025)
Cash flow-to-debt ratio of Biomind Labs Inc from 2021 to 2025. Historical debt coverage capacity for Biomind Labs Inc across 5 annual periods. Check BMND cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Biomind Labs Inc Cash Flow-to-Debt Ratio by Year (2021–2025)
Biomind Labs Inc cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Biomind Labs Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Biomind Labs Inc.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | CA$-67.55K | CA$1.74 Million | ▲ +85.3% |
| 2024 | -0.26x | CA$-354.43K | CA$1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | CA$-765.93K | CA$1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | CA$-2.15 Million | CA$336.72K | ▼ -0.8% |
| 2021 | -6.34x | CA$-2.12 Million | CA$334.95K | — |